Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) is an autosomal recessive disorder characterized by ptosis and progressive external ophthalmoplegia, peripheral neuropathy, severe gastrointestinal dysmotility, cachexia, leukoencephalopathy and mitochondrial DNA depletion, multiple deletions, or both. This disorder is caused by loss-of-function mutations in the gene encoding thymidine phosphorylase (TP) a cytosolic enzyme that catalyzes phosphorolysis of thymidine to thymine and deoxyribose 1-phosphate. In MNGIE patients. TP activity is very low or absent resulting in dramatically elevated levels of plasma thymidine and deoxyuridine. TP is expressed in most human tissues but is not expressed in skeletal muscle usually affected in MNGIE suggesting that TP deficiency causes the disease through a toxic intermediate. In addition, TP is associated with angiogenesis and high concentrations of thymidine inhibit microvessels formation. In our preliminary study vessels number between two MINGIE patients and eleven controls was compared. Histologic slides were stained with Alkaline Phosphatase and ratio between blood vessels and fibres number was calculated for each sample. Even if cases and controls numbers are low and they have to be increased, a significative differerence between MINGIE and control patients was revealed suggesting that angiogenesis inhibition could be involved in MINGIE pathogenesis.

Skeletal muscle pathology in MNGIE patients: blood vessels depletion

SALAROLI, ROBERTA;PAPA, VALENTINA;BOSCHETTI, ELISA;DE GIORGIO, ROBERTO;CARELLI, VALERIO;RINALDI, RITA;CENACCHI, GIOVANNA
2014

Abstract

Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) is an autosomal recessive disorder characterized by ptosis and progressive external ophthalmoplegia, peripheral neuropathy, severe gastrointestinal dysmotility, cachexia, leukoencephalopathy and mitochondrial DNA depletion, multiple deletions, or both. This disorder is caused by loss-of-function mutations in the gene encoding thymidine phosphorylase (TP) a cytosolic enzyme that catalyzes phosphorolysis of thymidine to thymine and deoxyribose 1-phosphate. In MNGIE patients. TP activity is very low or absent resulting in dramatically elevated levels of plasma thymidine and deoxyuridine. TP is expressed in most human tissues but is not expressed in skeletal muscle usually affected in MNGIE suggesting that TP deficiency causes the disease through a toxic intermediate. In addition, TP is associated with angiogenesis and high concentrations of thymidine inhibit microvessels formation. In our preliminary study vessels number between two MINGIE patients and eleven controls was compared. Histologic slides were stained with Alkaline Phosphatase and ratio between blood vessels and fibres number was calculated for each sample. Even if cases and controls numbers are low and they have to be increased, a significative differerence between MINGIE and control patients was revealed suggesting that angiogenesis inhibition could be involved in MINGIE pathogenesis.
EUROPEAN JOURNAL OF HISTOCHEMISTRY
R. Salaroli; V. Papa; E. Boschetti; R. De Giorgio; V. Carelli; R. Rinaldi; G. Cenacchi
File in questo prodotto:
File Dimensione Formato  
2466-Article Text-13797-1-10-20141127.pdf

accesso aperto

Tipo: Versione (PDF) editoriale
Licenza: Licenza per Accesso Aperto. Creative Commons Attribuzione - Non commerciale (CCBYNC)
Dimensione 637.36 kB
Formato Adobe PDF
637.36 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11585/414374
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact